Fibrin glue-assisted sutureless posterior chamber intraocular lens implantation in eyes with deficient posterior capsules.

TL;DR: In this paper , the authors conducted a systematic review and meta-analysis to assess the surgical and refractive outcomes of the sutureless scleral fixation (SSF) Carlevale IOL.

Abstract: Background/Objectives: The purpose of this study was evaluation of the efficacy and the rate of complication of a foldable sutureless scleral-fixated intraocular lens (SSF-IOL), named Carlevale IOL, for the treatment of aphakia without sufficient capsular support due to trauma or complicated cataract surgery. Methods: Retrospective, consecutive interventional case series. All consecutive eyes with secondary implantation of aphakic SSF-IOL were considered. The primary outcomes were as follows: best corrected visual acuity (BCVA), refractive error (RE), and intraocular pressure (IOP). Secondary outcome was the occurrence of intraoperative and postoperative complications. Results: SSF-IOL was performed in 21 eyes of 21 patients (7 men and 14 women) with mean age of 74 years (range from 36 to 90 years). The mean follow-up time was 11.4 months. VA improved significantly (p = 0.0007) from 0.38 logMAR at baseline to 0.11 logMAR at the final follow-up. BCVA improved in 18 patients, remained equal in 2 cases, and worsened in 1 case. Mean postoperative RE was −0.83 Diopters (D) (Median = −0.50 D, SD = 1.05 D) and it was less than 1D in 61.9% of patients. Mean IOP at the end of the follow-up was 15.78 mmHg (ranged from 10 to 22 mmHg, SD = 3.65). In one patient a vitreous hemorrhage was observed intraoperatively, but it resolved spontaneously. Postoperative complications included one case of cystoid macular edema and one case of epiretinal membrane. Conclusions: Carlevale SSF-IOL implantation seems to be an effective and safe procedure, ensuring good visual outcomes with a low rate of complication in eyes indicated for secondary IOL implantation.

TL;DR: A 78-year-old woman with subluxed diffractive IOLs has significant visual impairment due to various eye conditions. Further testing is needed to determine the best treatment options, including the need for IOL exchange, considering her comorbidities and overall health.

TL;DR: In this paper , a method to prepare autologous bio-based fibrin glue (FG) for use in ophthalmic surgery was proposed, and the clinical safety and efficacy were studied in rabbit eyes in conjunctival surgery.

TL;DR: The use of larger diameter polypropylene suture material and placement of the haptic and sutures in the ciliary sulcus to promote attachment of scar tissue may enhance the long‐term stability of scleral‐fixated PCIOLs.

TL;DR: In this article, a transscleral fixation of a posterior chamber intraocular lens (IOL) has been described as a method of repositioning posteriorly dislocated IOLs or implanting IOL in the absence of posterior capsular support.

TL;DR: Iris fixation of posterior chamber silicone IOLs may decrease the possibility of late suture breakage and dislocation of the IOL, as well as the risk of endophthalmitis.

TL;DR: Surgeons using scleral fixation of a posterior chamber IOL should be aware of the possibility of inducing tilt and should aim for symmetrical suture configurations at the two haptics.